- Home
- CYCN vs KDLY Comparison
CYCN vs KDLY Comparison
Compare CYCN & KDLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCN
- KDLY
- Stock Information
- Founded
- CYCN 2018
- KDLY 2019
- Country
- CYCN United States
- KDLY United States
- Employees
- CYCN N/A
- KDLY N/A
- Industry
- CYCN Biotechnology: Pharmaceutical Preparations
- KDLY
- Sector
- CYCN Health Care
- KDLY
- Exchange
- CYCN Nasdaq
- KDLY NYSE
- Market Cap
- CYCN 8.4M
- KDLY 19.6M
- IPO Year
- CYCN N/A
- KDLY 2024
- Fundamental
- Price
- CYCN $3.12
- KDLY $2.89
- Analyst Decision
- CYCN
- KDLY
- Analyst Count
- CYCN 0
- KDLY 0
- Target Price
- CYCN N/A
- KDLY N/A
- AVG Volume (30 Days)
- CYCN 5.8M
- KDLY 12.8M
- Earning Date
- CYCN 03-04-2025
- KDLY 02-25-2025
- Dividend Yield
- CYCN N/A
- KDLY N/A
- EPS Growth
- CYCN N/A
- KDLY N/A
- EPS
- CYCN N/A
- KDLY N/A
- Revenue
- CYCN $194,000.00
- KDLY $2,875,400.00
- Revenue This Year
- CYCN N/A
- KDLY N/A
- Revenue Next Year
- CYCN N/A
- KDLY N/A
- P/E Ratio
- CYCN N/A
- KDLY N/A
- Revenue Growth
- CYCN N/A
- KDLY N/A
- 52 Week Low
- CYCN $1.27
- KDLY $0.65
- 52 Week High
- CYCN $9.47
- KDLY $5.25
- Technical
- Relative Strength Index (RSI)
- CYCN 46.78
- KDLY N/A
- Support Level
- CYCN $2.81
- KDLY N/A
- Resistance Level
- CYCN $4.80
- KDLY N/A
- Average True Range (ATR)
- CYCN 0.76
- KDLY 0.00
- MACD
- CYCN -0.08
- KDLY 0.00
- Stochastic Oscillator
- CYCN 20.76
- KDLY 0.00
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
About KDLY KINDLY MD INC
Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.